Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2026)
Treace Medical Concepts (TMCI) reported Interest & Investment Income of $501000.0 for Q1 2026, down 40.43% on a YoY basis from $841000.0 in Q1 2025, and down 4.93% quarter-over-quarter from $527000.0 in Q4 2025.
Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2026) Analysis & Trends
Treace Medical Concepts has reported Interest & Investment Income for 7 years, with the latest figure at $501000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 40.43% year-over-year to $501000.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (down 41.74% YoY), and the FY2025 full-year result was $2.8 million, down 43.06% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $501000.0, down from $527000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $2.0 million in Q2 2023, with the low at $9000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $952588.2 across 5 years, with a median of $841000.0 in 2025.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 16333.33% — and 2024, when it sank 47.4%.
- Treace Medical Concepts' Interest & Investment Income stood at $753000.0 in 2022, then surged by 126.96% to $1.7 million in 2023, then sank by 47.4% to $899000.0 in 2024, then slumped by 41.38% to $527000.0 in 2025, then decreased by 4.93% to $501000.0 in 2026.
- The last three Interest & Investment Income figures came in at $501000.0 (Q1 2026), $527000.0 (Q4 2025), and $634000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 33.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 40.98 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Treace Medical Concepts | 262.89 Mn | 211.04 Mn | 37.41 Mn | 501,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 501,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 775,000.00 |
| Mar 31, 2025 | 841,000.00 |
| Dec 31, 2024 | 899,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 753,000.00 |
| Sep 30, 2022 | 420,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 6,000.00 |